Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥65 years) with type 2 diabetes

Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥65 years) with type 2 diabetes

Bibliographic Details
Main Authors:	Iqbal, Nayyar, Allen, Elsie, Öhman, Peter
Format:	Online
Language:	English
Published:	Dove Medical Press 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158996/

Similar Items

Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus
by: Karyekar, Chetan S, et al.
Published: (2013)

Efficacy and Safety of Saxagliptin as Add-On Therapy in Type 2 Diabetes
by: Neumiller, Joshua J.
Published: (2014)

Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin
by: Pia S. Pollack, et al.
Published: (2017-09-01)

Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment
by: Perl, Shira, et al.
Published: (2016)

Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials
by: Iqbal, Nayyar, et al.
Published: (2014)

Radical Prostatectomy in Korean Men Aged 75-Years or Older: Safety and Efficacy in Comparison with Patients Aged 65–69 Years
by: Ryu, Jae Hyun, et al.
Published: (2016)

Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents
by: Li, Chun-Jun, et al.
Published: (2014)

Utility of Saxagliptin in the Treatment of Type 2 Diabetes: Review of Efficacy and Safety
by: Jain, Rajeev
Published: (2015)

Laparoscopic Surgery in Elderly Patients Aged 65 Years and Older with Gynecologic Disease
by: Kanasaki, Haruhiko, et al.
Published: (2012)

Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study
by: Wohlreich, Madelaine M, et al.
Published: (2004)

The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
by: Jackson, Robert L, et al.
Published: (2012)

Similar efficacy and safety of once‐weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years
by: Boustani, M. A., et al.
Published: (2016)

Long-term survival after surgical aortic valve replacement among patients over 65 years of age
by: Sharabiani, Mansour T A, et al.
Published: (2016)

Comparison of charges and resource use associated with saxagliptin and sitagliptin
by: Vaidya, Varun, et al.
Published: (2016)

Effects of saxagliptin add-on therapy to insulin on blood glycemic fluctuations in patients with type 2 diabetes: A randomized, control, open-labeled trial
by: Li, Feng-fei, et al.
Published: (2016)

Dialysis outcomes in those aged ≥65 years
by: Walker, Robert, et al.
Published: (2013)

Mortality in Hemodialysis Patients Over 65 Years of Age
by: Coric, Aida, et al.
Published: (2015)

Drypoint adds safety to aircraft manufacture
Published: (2004)

The Efficacy and Safety of Microvascular Decompression for Idiopathic Trigeminal Neuralgia in Patients Older Than 65 Years
by: Yang, De-bao, et al.
Published: (2014)

Subjective quality of life of those 65 years and older experiencing dementia.
by: Stewart-Archer, L., et al.
Published: (2015)

Strength and Functional Characteristics of Men and Women 65 Years and Older
by: Peiffer, J., et al.
Published: (2010)

The Impact of Real-Time Continuous Glucose Monitoring in Patients 65 Years and Older
by: Polonsky, William H., et al.
Published: (2016)

Cervical Screening at Age 50–64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study
by: Castañón, Alejandra, et al.
Published: (2014)

The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone
by: DeFronzo, Ralph A., et al.
Published: (2009)

Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular disease
by: Toth, Peter P
Published: (2014)

Tocilizumab in refractory rheumatoid arthritis: long-term efficacy, safety, and tolerability beyond 2 years
by: Farah, Ziad, et al.
Published: (2016)

Detection of mild cognitive impairment in people older than 65 years of age and its relationship to cardiovascular risk factors (DECRIVAM)
by: Perea-Bartolome, M Victoria, et al.
Published: (2011)

Endoscopic gallbladder stenting for acute cholecystitis: a retrospective study of 46 elderly patients aged 65 years or older
by: Maekawa, Satoshi, et al.
Published: (2013)

Diet Quality Is Associated with All-Cause Mortality in Adults Aged 65 Years and Older123
by: McNaughton, Sarah A., et al.
Published: (2012)

Mortality from Unspecified Unintentional Injury among Individuals Aged 65 Years and Older by U.S. State, 1999–2013
by: Cheng, Xunjie, et al.
Published: (2016)

Remaining Life Expectancy With and Without Polypharmacy: A Register-Based Study of Swedes Aged 65 Years and Older
by: Wastesson, Jonas W., et al.
Published: (2016)

Low serum albumin and total lymphocyte count as predictors of 30 day hospital readmission in patients 65 years of age or older
by: Robinson, Robert
Published: (2015)

Association of Physical Performance and Pain With Fear of Falling Among Community—Dwelling Japanese Women Aged 65 Years and Older
by: Tomita, Yoshihito, et al.
Published: (2015)

Pregnancy hypertensive disease and risk of dementia and cardiovascular disease in women aged 65 years or older: a cohort study
by: Nelander, M, et al.
Published: (2016)

Does attending an exercise class with a spouse improve long-term exercise adherence among people aged 65 years and older: a 6-month prospective follow-up study
by: Yosuke Osuka, et al.
Published: (2017-07-01)

Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data
by: Cobble, Michael E, et al.
Published: (2012)

Treatment of type 2 diabetes with saxagliptin: a pharmacoeconomic evaluation in Argentina
by: Elgart, Jorge F, et al.
Published: (2013)

Saxagliptin and Metformin in Fixed Combination for the Treatment of Type 2 Diabetes in Adults
by: Minze, Molly G., et al.
Published: (2013)

Clinical outcomes, not clinical utility, should be the major consideration for saxagliptin with or without metformin
by: Doggrell, Sheila A
Published: (2014)

Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes
by: Ott, Christian, et al.
Published: (2014)